IFRXInflaRx N.V.

IFRX Stock Price, Valuation & Chart | InflaRx N.V.

Compare

$2.290+0.13 (+6.02%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology IFRX intrinsic value IFRX calculated fair value vs price

Overview Financials Dividends Ratios

IFRX Historical price chart

IFRX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization337.30M

PE Ratio-4.32

EPS-0.53

Trading Volume567.83K

Today's High/Low2.34/2.13

Dividend Yield0.00

52 Week High/Low2.95/0.8

Shares Outstanding147.29M

IFRX Financial Statement

IFRX Analyst ratings

IFRX Analysis & performance metrics

IFRX Company profile

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a…

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class…

IFRX Management team

Name

Position

Christian Schmid

Vice President and Head of Legal Affairs & General Counsel

Renfeng Guo M.D.CTO

Co-Founder, Chief Scientific Officer & Executive Director

Camilla Chong M.D.

Chief Medical Officer

Derval O'Carroll

Senior Vice President and Global Head of Regulatory Affairs & Compliance

Bruce P. Burnett Ph.D.

Vice President & Head of Medical Affairs

Jan Medina CFA

Head of Investor Relations & Vice President

Niels C. Riedemann M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer & Executive Director

Thomas Taapken Ph.D.CFO

Chief Financial Officer

Name

Position

Christian Schmid

Vice President and Head of Legal Affairs & General Counsel

Renfeng Guo M.D.CTO

Co-Founder, Chief Scientific Officer & Executive Director

Camilla Chong M.D.

Chief Medical Officer

Derval O'Carroll

Senior Vice President and Global Head of Regulatory Affairs & Compliance

Bruce P. Burnett Ph.D.

Vice President & Head of Medical Affairs

Jan Medina CFA

Head of Investor Relations & Vice President

Niels C. Riedemann M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer & Executive Director

Thomas Taapken Ph.D.CFO

Chief Financial Officer

Management Team

Christian Schmid

Vice President and Head of Legal Affairs & General Counsel

Renfeng Guo M.D.CTO

Co-Founder, Chief Scientific Officer & Executive Director

Camilla Chong M.D.

Chief Medical Officer

Derval O'Carroll

Senior Vice President and Global Head of Regulatory Affairs & Compliance

Bruce P. Burnett Ph.D.

Vice President & Head of Medical Affairs

Jan Medina CFA

Head of Investor Relations & Vice President

Niels C. Riedemann M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer & Executive Director

Thomas Taapken Ph.D.CFO

Chief Financial Officer

Management

Christian Schmid

Vice President and Head of Legal Affairs & General Counsel

Renfeng Guo M.D.CTO

Co-Founder, Chief Scientific Officer & Executive Director

Camilla Chong M.D.

Chief Medical Officer

Derval O'Carroll

Senior Vice President and Global Head of Regulatory Affairs & Compliance

Bruce P. Burnett Ph.D.

Vice President & Head of Medical Affairs

Jan Medina CFA

Head of Investor Relations & Vice President

Niels C. Riedemann M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer & Executive Director

Thomas Taapken Ph.D.CFO

Chief Financial Officer

Total 8 executives

IFRX Frequently asked questions

What is InflaRx N.V. (IFRX) Stock Price?

Current stock price of InflaRx N.V. (IFRX) stock is $2.290. The stock price is +6.02% higher in the session. The intraday range can be seen from this page. Volume of InflaRx N.V. (IFRX) stock is 567.83K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the InflaRx N.V. (IFRX) stock price going up or down today?

The stock price of InflaRx N.V. (IFRX) can change with earnings, company news, and overall market sentiment. InflaRx N.V. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the InflaRx N.V. stock expensive at its current price?

Whether InflaRx N.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IFRX on this page is -4.32. EPS on this page is -0.53. Compare those figures with peers and growth expectations before deciding if the current InflaRx N.V. price is justified.

How has the stock price of InflaRx N.V. (IFRX) performed historically?

Historical performance for InflaRx N.V. (IFRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IFRX reacted to past earnings and market events.

Should I buy InflaRx N.V. (IFRX) stock, at this price?

Buying InflaRx N.V. (IFRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.